averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF652
|
ENSG00000198740.4 | zinc finger protein 652 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_111782696 | 37.94 |
ENST00000227251.3
ENST00000526180.1 |
CRYAB
|
crystallin, alpha B |
chrX_+_103031758 | 33.99 |
ENST00000303958.2
ENST00000361621.2 |
PLP1
|
proteolipid protein 1 |
chr11_-_111782484 | 32.34 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
chr16_+_56623433 | 30.40 |
ENST00000570176.1
|
MT3
|
metallothionein 3 |
chr4_-_90757364 | 29.55 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr4_-_165898768 | 19.82 |
ENST00000329314.5
|
TRIM61
|
tripartite motif containing 61 |
chr10_-_15413035 | 19.19 |
ENST00000378116.4
ENST00000455654.1 |
FAM171A1
|
family with sequence similarity 171, member A1 |
chr11_-_119293872 | 18.08 |
ENST00000524970.1
|
THY1
|
Thy-1 cell surface antigen |
chr1_+_169077172 | 17.24 |
ENST00000499679.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr4_-_90756769 | 16.71 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr14_-_21493884 | 16.64 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
chr15_+_68871569 | 16.57 |
ENST00000566799.1
|
CORO2B
|
coronin, actin binding protein, 2B |
chr14_-_21493649 | 16.17 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
chr9_-_35111570 | 15.41 |
ENST00000378561.1
ENST00000603301.1 |
FAM214B
|
family with sequence similarity 214, member B |
chr8_-_110656995 | 15.18 |
ENST00000276646.9
ENST00000533065.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
chr17_+_48172639 | 15.11 |
ENST00000503176.1
ENST00000503614.1 |
PDK2
|
pyruvate dehydrogenase kinase, isozyme 2 |
chr19_+_37998031 | 14.69 |
ENST00000586138.1
ENST00000588578.1 ENST00000587986.1 |
ZNF793
|
zinc finger protein 793 |
chr14_-_101034407 | 14.51 |
ENST00000443071.2
ENST00000557378.1 |
BEGAIN
|
brain-enriched guanylate kinase-associated |
chr19_-_18508396 | 14.18 |
ENST00000595840.1
ENST00000339007.3 |
LRRC25
|
leucine rich repeat containing 25 |
chr16_-_57318566 | 14.13 |
ENST00000569059.1
ENST00000219207.5 |
PLLP
|
plasmolipin |
chr17_-_79139817 | 14.13 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
chr9_-_35111420 | 12.64 |
ENST00000378557.1
|
FAM214B
|
family with sequence similarity 214, member B |
chr11_-_35547572 | 12.26 |
ENST00000378880.2
|
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
chr6_+_39760783 | 12.20 |
ENST00000398904.2
ENST00000538976.1 |
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
chr2_-_99224915 | 12.10 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
chr17_+_48610074 | 12.02 |
ENST00000503690.1
ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3
|
epsin 3 |
chr3_+_158991025 | 11.85 |
ENST00000337808.6
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
chr2_-_218808771 | 11.58 |
ENST00000449814.1
ENST00000171887.4 |
TNS1
|
tensin 1 |
chr19_+_41509851 | 11.43 |
ENST00000593831.1
ENST00000330446.5 |
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
chr5_-_176057365 | 11.29 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
chr5_-_176057518 | 11.19 |
ENST00000393693.2
|
SNCB
|
synuclein, beta |
chr14_+_85996471 | 10.81 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr17_+_47865917 | 10.75 |
ENST00000259021.4
ENST00000454930.2 ENST00000509773.1 ENST00000510819.1 ENST00000424009.2 |
KAT7
|
K(lysine) acetyltransferase 7 |
chr11_-_35547151 | 10.42 |
ENST00000378878.3
ENST00000529303.1 ENST00000278360.3 |
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
chr1_-_203320617 | 10.34 |
ENST00000354955.4
|
FMOD
|
fibromodulin |
chr1_+_152635854 | 9.86 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
chr4_-_99578776 | 9.74 |
ENST00000515287.1
|
TSPAN5
|
tetraspanin 5 |
chr4_-_99578789 | 8.99 |
ENST00000511651.1
ENST00000505184.1 |
TSPAN5
|
tetraspanin 5 |
chr14_-_22005343 | 8.96 |
ENST00000327430.3
|
SALL2
|
spalt-like transcription factor 2 |
chr11_-_128894053 | 8.29 |
ENST00000392657.3
|
ARHGAP32
|
Rho GTPase activating protein 32 |
chr16_+_24266874 | 8.27 |
ENST00000005284.3
|
CACNG3
|
calcium channel, voltage-dependent, gamma subunit 3 |
chr15_+_25200074 | 8.20 |
ENST00000390687.4
ENST00000584968.1 ENST00000346403.6 ENST00000554227.2 |
SNRPN
|
small nuclear ribonucleoprotein polypeptide N |
chr15_+_68871308 | 8.19 |
ENST00000261861.5
|
CORO2B
|
coronin, actin binding protein, 2B |
chr1_+_168148273 | 8.18 |
ENST00000367830.3
|
TIPRL
|
TIP41, TOR signaling pathway regulator-like (S. cerevisiae) |
chr14_-_45431091 | 8.07 |
ENST00000579157.1
ENST00000396128.4 ENST00000556500.1 |
KLHL28
|
kelch-like family member 28 |
chr1_-_156647189 | 7.98 |
ENST00000368223.3
|
NES
|
nestin |
chr11_-_86383157 | 7.69 |
ENST00000393324.3
|
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial |
chr14_-_22005062 | 7.41 |
ENST00000317492.5
|
SALL2
|
spalt-like transcription factor 2 |
chr2_+_99797542 | 7.34 |
ENST00000338148.3
ENST00000512183.2 |
MRPL30
C2orf15
|
mitochondrial ribosomal protein L30 chromosome 2 open reading frame 15 |
chr3_-_127441406 | 7.30 |
ENST00000487473.1
ENST00000484451.1 |
MGLL
|
monoglyceride lipase |
chr12_+_6982725 | 7.29 |
ENST00000433346.1
|
LRRC23
|
leucine rich repeat containing 23 |
chr6_+_45296391 | 7.26 |
ENST00000371436.6
ENST00000576263.1 |
RUNX2
|
runt-related transcription factor 2 |
chr19_+_10531150 | 7.25 |
ENST00000352831.6
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
chr6_+_72926145 | 7.18 |
ENST00000425662.2
ENST00000453976.2 |
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr11_+_123396528 | 7.17 |
ENST00000322282.7
ENST00000529750.1 |
GRAMD1B
|
GRAM domain containing 1B |
chr15_+_73976715 | 6.66 |
ENST00000558689.1
ENST00000560786.2 ENST00000561213.1 ENST00000563584.1 ENST00000561416.1 |
CD276
|
CD276 molecule |
chr11_-_86383370 | 6.65 |
ENST00000526834.1
ENST00000359636.2 |
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial |
chr1_-_161279749 | 6.64 |
ENST00000533357.1
ENST00000360451.6 ENST00000336559.4 |
MPZ
|
myelin protein zero |
chr7_+_23286182 | 6.56 |
ENST00000258733.4
ENST00000381990.2 ENST00000409458.3 ENST00000539136.1 ENST00000453162.2 |
GPNMB
|
glycoprotein (transmembrane) nmb |
chr11_-_89224508 | 6.49 |
ENST00000525196.1
|
NOX4
|
NADPH oxidase 4 |
chr11_+_57365150 | 6.46 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr5_+_81575281 | 6.36 |
ENST00000380167.4
|
ATP6AP1L
|
ATPase, H+ transporting, lysosomal accessory protein 1-like |
chr19_+_17326191 | 6.35 |
ENST00000595101.1
ENST00000596136.1 ENST00000379776.4 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr17_-_40333099 | 6.29 |
ENST00000607371.1
|
KCNH4
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
chr16_-_1843720 | 6.27 |
ENST00000415638.3
ENST00000215539.3 |
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit |
chr5_+_125758813 | 6.19 |
ENST00000285689.3
ENST00000515200.1 |
GRAMD3
|
GRAM domain containing 3 |
chr3_+_193965426 | 6.11 |
ENST00000455821.1
|
RP11-513G11.3
|
RP11-513G11.3 |
chr3_+_157154578 | 6.10 |
ENST00000295927.3
|
PTX3
|
pentraxin 3, long |
chr1_+_22351977 | 6.00 |
ENST00000420503.1
ENST00000416769.1 ENST00000404210.2 |
LINC00339
|
long intergenic non-protein coding RNA 339 |
chr5_-_16936340 | 5.97 |
ENST00000507288.1
ENST00000513610.1 |
MYO10
|
myosin X |
chr18_+_32621324 | 5.94 |
ENST00000300249.5
ENST00000538170.2 ENST00000588910.1 |
MAPRE2
|
microtubule-associated protein, RP/EB family, member 2 |
chr10_-_28571015 | 5.92 |
ENST00000375719.3
ENST00000375732.1 |
MPP7
|
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
chr2_-_220174166 | 5.86 |
ENST00000409251.3
ENST00000451506.1 ENST00000295718.2 ENST00000446182.1 |
PTPRN
|
protein tyrosine phosphatase, receptor type, N |
chr16_+_67927147 | 5.84 |
ENST00000291041.5
|
PSKH1
|
protein serine kinase H1 |
chr14_-_23772032 | 5.77 |
ENST00000452015.4
|
PPP1R3E
|
protein phosphatase 1, regulatory subunit 3E |
chr16_-_71610985 | 5.74 |
ENST00000355962.4
|
TAT
|
tyrosine aminotransferase |
chr19_-_53400813 | 5.67 |
ENST00000595635.1
ENST00000594741.1 ENST00000597111.1 ENST00000593618.1 ENST00000597909.1 |
ZNF320
|
zinc finger protein 320 |
chr16_-_66584059 | 5.66 |
ENST00000417693.3
ENST00000544898.1 ENST00000569718.1 ENST00000527284.1 ENST00000299697.7 ENST00000451102.2 |
TK2
|
thymidine kinase 2, mitochondrial |
chr15_+_75639951 | 5.64 |
ENST00000564784.1
ENST00000569035.1 |
NEIL1
|
nei endonuclease VIII-like 1 (E. coli) |
chr5_+_125758865 | 5.64 |
ENST00000542322.1
ENST00000544396.1 |
GRAMD3
|
GRAM domain containing 3 |
chr13_+_42846272 | 5.63 |
ENST00000025301.2
|
AKAP11
|
A kinase (PRKA) anchor protein 11 |
chr3_-_9994021 | 5.50 |
ENST00000411976.2
ENST00000412055.1 |
PRRT3
|
proline-rich transmembrane protein 3 |
chr2_+_11052054 | 5.49 |
ENST00000295082.1
|
KCNF1
|
potassium voltage-gated channel, subfamily F, member 1 |
chr14_+_85996507 | 5.48 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr12_-_49393092 | 5.41 |
ENST00000421952.2
|
DDN
|
dendrin |
chr13_-_38172863 | 5.37 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
chr6_+_126102292 | 5.31 |
ENST00000368357.3
|
NCOA7
|
nuclear receptor coactivator 7 |
chr11_+_111782934 | 5.26 |
ENST00000304298.3
|
HSPB2
|
Homo sapiens heat shock 27kDa protein 2 (HSPB2), mRNA. |
chr18_+_32558208 | 5.22 |
ENST00000436190.2
|
MAPRE2
|
microtubule-associated protein, RP/EB family, member 2 |
chr11_+_107461948 | 5.09 |
ENST00000265840.7
ENST00000443271.2 |
ELMOD1
|
ELMO/CED-12 domain containing 1 |
chr3_+_46449049 | 5.05 |
ENST00000357392.4
ENST00000400880.3 ENST00000433848.1 |
CCRL2
|
chemokine (C-C motif) receptor-like 2 |
chr16_+_31483451 | 5.00 |
ENST00000565360.1
ENST00000361773.3 |
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
chr17_-_47755338 | 4.98 |
ENST00000508805.1
ENST00000515508.2 ENST00000451526.2 ENST00000507970.1 |
SPOP
|
speckle-type POZ protein |
chr2_-_86564776 | 4.91 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
chr16_+_31483374 | 4.86 |
ENST00000394863.3
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
chr20_-_36793774 | 4.78 |
ENST00000361475.2
|
TGM2
|
transglutaminase 2 |
chr11_-_89224139 | 4.76 |
ENST00000413594.2
|
NOX4
|
NADPH oxidase 4 |
chr12_-_27167233 | 4.69 |
ENST00000535819.1
ENST00000543803.1 ENST00000535423.1 ENST00000539741.1 ENST00000343028.4 ENST00000545600.1 ENST00000543088.1 |
TM7SF3
|
transmembrane 7 superfamily member 3 |
chr3_-_9885626 | 4.63 |
ENST00000424438.1
ENST00000433555.1 ENST00000427174.1 ENST00000418713.1 ENST00000433535.2 ENST00000383820.5 ENST00000433972.1 |
RPUSD3
|
RNA pseudouridylate synthase domain containing 3 |
chr12_+_20848486 | 4.56 |
ENST00000545102.1
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1 |
chr14_+_59104741 | 4.49 |
ENST00000395153.3
ENST00000335867.4 |
DACT1
|
dishevelled-binding antagonist of beta-catenin 1 |
chr14_-_88459503 | 4.36 |
ENST00000393568.4
ENST00000261304.2 |
GALC
|
galactosylceramidase |
chr6_-_28226984 | 4.33 |
ENST00000423974.2
|
ZKSCAN4
|
zinc finger with KRAB and SCAN domains 4 |
chr17_-_6554877 | 4.30 |
ENST00000225728.3
ENST00000575197.1 |
MED31
|
mediator complex subunit 31 |
chr19_+_17326141 | 4.30 |
ENST00000445667.2
ENST00000263897.5 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr2_+_162016827 | 4.24 |
ENST00000429217.1
ENST00000406287.1 ENST00000402568.1 |
TANK
|
TRAF family member-associated NFKB activator |
chr8_-_23261589 | 4.23 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
chr17_+_26800648 | 4.21 |
ENST00000545060.1
|
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr14_+_79745746 | 4.20 |
ENST00000281127.7
|
NRXN3
|
neurexin 3 |
chr1_+_215747118 | 4.18 |
ENST00000448333.1
|
KCTD3
|
potassium channel tetramerization domain containing 3 |
chr8_-_17555164 | 4.13 |
ENST00000297488.6
|
MTUS1
|
microtubule associated tumor suppressor 1 |
chr18_-_5296138 | 4.13 |
ENST00000400143.3
|
ZBTB14
|
zinc finger and BTB domain containing 14 |
chrX_-_72347916 | 4.00 |
ENST00000373518.1
|
NAP1L6
|
nucleosome assembly protein 1-like 6 |
chr16_-_66583701 | 3.99 |
ENST00000527800.1
ENST00000525974.1 ENST00000563369.2 |
TK2
|
thymidine kinase 2, mitochondrial |
chr12_+_8995832 | 3.96 |
ENST00000541459.1
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
chr10_-_101190202 | 3.91 |
ENST00000543866.1
ENST00000370508.5 |
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble |
chr1_+_156611704 | 3.85 |
ENST00000329117.5
|
BCAN
|
brevican |
chr11_-_89224638 | 3.85 |
ENST00000535633.1
ENST00000263317.4 |
NOX4
|
NADPH oxidase 4 |
chr12_+_20848377 | 3.81 |
ENST00000540354.1
ENST00000266509.2 ENST00000381552.1 |
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1 |
chr19_-_14316980 | 3.78 |
ENST00000361434.3
ENST00000340736.6 |
LPHN1
|
latrophilin 1 |
chrX_-_44202857 | 3.73 |
ENST00000420999.1
|
EFHC2
|
EF-hand domain (C-terminal) containing 2 |
chr14_+_79746249 | 3.73 |
ENST00000428277.2
|
NRXN3
|
neurexin 3 |
chr12_+_133757995 | 3.71 |
ENST00000536435.2
ENST00000228289.5 ENST00000541211.2 ENST00000500625.3 ENST00000539248.2 ENST00000542711.2 ENST00000536899.2 ENST00000542986.2 ENST00000537565.1 ENST00000541975.2 |
ZNF268
|
zinc finger protein 268 |
chr17_-_33416231 | 3.68 |
ENST00000584655.1
ENST00000447669.2 ENST00000315249.7 |
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
chr9_-_123812542 | 3.63 |
ENST00000223642.1
|
C5
|
complement component 5 |
chr2_-_182545603 | 3.51 |
ENST00000295108.3
|
NEUROD1
|
neuronal differentiation 1 |
chr22_+_29702572 | 3.49 |
ENST00000407647.2
ENST00000416823.1 ENST00000428622.1 |
GAS2L1
|
growth arrest-specific 2 like 1 |
chr1_+_22333943 | 3.48 |
ENST00000400271.2
|
CELA3A
|
chymotrypsin-like elastase family, member 3A |
chr14_+_79745682 | 3.47 |
ENST00000557594.1
|
NRXN3
|
neurexin 3 |
chr5_+_135394840 | 3.45 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr5_-_153857819 | 3.44 |
ENST00000231121.2
|
HAND1
|
heart and neural crest derivatives expressed 1 |
chr16_-_49890016 | 3.43 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
chr3_+_53528659 | 3.43 |
ENST00000350061.5
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
chr5_-_114598548 | 3.42 |
ENST00000379615.3
ENST00000419445.1 |
PGGT1B
|
protein geranylgeranyltransferase type I, beta subunit |
chr6_+_44238203 | 3.40 |
ENST00000451188.2
|
TMEM151B
|
transmembrane protein 151B |
chr3_-_133648656 | 3.40 |
ENST00000408895.2
|
C3orf36
|
chromosome 3 open reading frame 36 |
chr22_-_24641027 | 3.37 |
ENST00000398292.3
ENST00000263112.7 ENST00000418439.2 ENST00000424217.1 ENST00000327365.4 |
GGT5
|
gamma-glutamyltransferase 5 |
chr21_+_40817749 | 3.37 |
ENST00000380637.3
ENST00000380634.1 ENST00000458295.1 ENST00000440288.2 ENST00000380631.1 |
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
chr15_+_71185148 | 3.35 |
ENST00000443425.2
ENST00000560755.1 |
LRRC49
|
leucine rich repeat containing 49 |
chr17_-_41985096 | 3.34 |
ENST00000269095.4
ENST00000523220.1 |
MPP2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr3_+_38080691 | 3.30 |
ENST00000308059.6
ENST00000346219.3 ENST00000452631.2 |
DLEC1
|
deleted in lung and esophageal cancer 1 |
chr17_+_26800296 | 3.30 |
ENST00000444914.3
ENST00000314669.5 |
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr2_+_177053307 | 3.29 |
ENST00000331462.4
|
HOXD1
|
homeobox D1 |
chr11_-_66103932 | 3.26 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
chr19_-_44174305 | 3.26 |
ENST00000601723.1
ENST00000339082.3 |
PLAUR
|
plasminogen activator, urokinase receptor |
chr2_-_208989225 | 3.23 |
ENST00000264376.4
|
CRYGD
|
crystallin, gamma D |
chr14_+_24867992 | 3.22 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr9_-_115983641 | 3.16 |
ENST00000238256.3
|
FKBP15
|
FK506 binding protein 15, 133kDa |
chr2_+_204193149 | 3.16 |
ENST00000422511.2
|
ABI2
|
abl-interactor 2 |
chr11_+_72975578 | 3.14 |
ENST00000393592.2
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
chr11_+_19798964 | 3.12 |
ENST00000527559.2
|
NAV2
|
neuron navigator 2 |
chr8_-_57359131 | 3.10 |
ENST00000518974.1
ENST00000523051.1 ENST00000518770.1 ENST00000451791.2 |
PENK
|
proenkephalin |
chr6_-_28220002 | 3.06 |
ENST00000377294.2
|
ZKSCAN4
|
zinc finger with KRAB and SCAN domains 4 |
chr6_-_89673280 | 3.04 |
ENST00000369475.3
ENST00000369485.4 ENST00000538899.1 ENST00000265607.6 |
RNGTT
|
RNA guanylyltransferase and 5'-phosphatase |
chr5_+_161494521 | 3.02 |
ENST00000356592.3
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
chr1_+_26485511 | 3.01 |
ENST00000374268.3
|
FAM110D
|
family with sequence similarity 110, member D |
chr4_-_74486347 | 2.97 |
ENST00000342081.3
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr4_-_74486217 | 2.96 |
ENST00000335049.5
ENST00000307439.5 |
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr20_-_17662705 | 2.95 |
ENST00000455029.2
|
RRBP1
|
ribosome binding protein 1 |
chr19_-_38720294 | 2.95 |
ENST00000412732.1
ENST00000456296.1 |
DPF1
|
D4, zinc and double PHD fingers family 1 |
chr1_-_150780757 | 2.93 |
ENST00000271651.3
|
CTSK
|
cathepsin K |
chr4_-_77134742 | 2.92 |
ENST00000452464.2
|
SCARB2
|
scavenger receptor class B, member 2 |
chr17_+_26800756 | 2.92 |
ENST00000537681.1
|
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr11_+_72975524 | 2.90 |
ENST00000540342.1
ENST00000542092.1 |
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
chr2_+_204193101 | 2.85 |
ENST00000430418.1
ENST00000424558.1 ENST00000261016.6 |
ABI2
|
abl-interactor 2 |
chr1_-_208417620 | 2.84 |
ENST00000367033.3
|
PLXNA2
|
plexin A2 |
chr10_-_100995540 | 2.82 |
ENST00000370546.1
ENST00000404542.1 |
HPSE2
|
heparanase 2 |
chr6_+_45296048 | 2.80 |
ENST00000465038.2
ENST00000352853.5 ENST00000541979.1 ENST00000371438.1 |
RUNX2
|
runt-related transcription factor 2 |
chr11_-_63381925 | 2.80 |
ENST00000415826.1
|
PLA2G16
|
phospholipase A2, group XVI |
chr4_+_71108300 | 2.77 |
ENST00000304954.3
|
CSN3
|
casein kappa |
chr22_-_38577782 | 2.76 |
ENST00000430886.1
ENST00000332509.3 ENST00000447598.2 ENST00000435484.1 ENST00000402064.1 ENST00000436218.1 |
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent) |
chr3_+_151531810 | 2.75 |
ENST00000232892.7
|
AADAC
|
arylacetamide deacetylase |
chr17_-_7120525 | 2.75 |
ENST00000447163.1
ENST00000399506.2 ENST00000302955.6 |
DLG4
|
discs, large homolog 4 (Drosophila) |
chr18_+_42260861 | 2.71 |
ENST00000282030.5
|
SETBP1
|
SET binding protein 1 |
chr22_-_38577731 | 2.67 |
ENST00000335539.3
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent) |
chr9_-_117853297 | 2.62 |
ENST00000542877.1
ENST00000537320.1 ENST00000341037.4 |
TNC
|
tenascin C |
chr16_-_87970122 | 2.62 |
ENST00000309893.2
|
CA5A
|
carbonic anhydrase VA, mitochondrial |
chr6_-_70992755 | 2.59 |
ENST00000370499.4
|
COL9A1
|
collagen, type IX, alpha 1 |
chr2_+_173940442 | 2.58 |
ENST00000409176.2
ENST00000338983.3 ENST00000431503.2 |
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
chr1_-_38019878 | 2.57 |
ENST00000296215.6
|
SNIP1
|
Smad nuclear interacting protein 1 |
chr9_+_107526443 | 2.57 |
ENST00000374762.3
|
NIPSNAP3B
|
nipsnap homolog 3B (C. elegans) |
chr1_+_78470530 | 2.55 |
ENST00000370763.5
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4 |
chr9_-_115983568 | 2.54 |
ENST00000446284.1
ENST00000414250.1 |
FKBP15
|
FK506 binding protein 15, 133kDa |
chr3_-_50336548 | 2.54 |
ENST00000450489.1
ENST00000513170.1 ENST00000450982.1 |
NAT6
HYAL3
|
N-acetyltransferase 6 (GCN5-related) hyaluronoglucosaminidase 3 |
chr1_-_221915418 | 2.53 |
ENST00000323825.3
ENST00000366899.3 |
DUSP10
|
dual specificity phosphatase 10 |
chr17_-_40264692 | 2.52 |
ENST00000591220.1
ENST00000251642.3 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr3_+_148457585 | 2.52 |
ENST00000402260.1
|
AGTR1
|
angiotensin II receptor, type 1 |
chr2_+_172378757 | 2.51 |
ENST00000409484.1
ENST00000321348.4 ENST00000375252.3 |
CYBRD1
|
cytochrome b reductase 1 |
chr2_-_188378368 | 2.50 |
ENST00000392365.1
ENST00000435414.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr7_-_142583506 | 2.48 |
ENST00000359396.3
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6 |
chr20_+_30946106 | 2.41 |
ENST00000375687.4
ENST00000542461.1 |
ASXL1
|
additional sex combs like 1 (Drosophila) |
chr1_+_101185290 | 2.40 |
ENST00000370119.4
ENST00000347652.2 ENST00000294728.2 ENST00000370115.1 |
VCAM1
|
vascular cell adhesion molecule 1 |
chr5_-_78281603 | 2.33 |
ENST00000264914.4
|
ARSB
|
arylsulfatase B |
chr5_+_76326187 | 2.32 |
ENST00000312916.7
ENST00000506806.1 |
AGGF1
|
angiogenic factor with G patch and FHA domains 1 |
chr11_-_59633951 | 2.31 |
ENST00000257264.3
|
TCN1
|
transcobalamin I (vitamin B12 binding protein, R binder family) |
chr11_+_72975559 | 2.29 |
ENST00000349767.2
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
chr2_+_204193129 | 2.28 |
ENST00000417864.1
|
ABI2
|
abl-interactor 2 |
chrX_+_68835911 | 2.25 |
ENST00000525810.1
ENST00000527388.1 ENST00000374553.2 ENST00000374552.4 ENST00000338901.3 ENST00000524573.1 |
EDA
|
ectodysplasin A |
chr8_-_87755878 | 2.21 |
ENST00000320005.5
|
CNGB3
|
cyclic nucleotide gated channel beta 3 |
chr11_-_119599794 | 2.20 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 30.4 | GO:0097212 | cadmium ion homeostasis(GO:0055073) lysosomal membrane organization(GO:0097212) negative regulation of hydrogen peroxide catabolic process(GO:2000296) regulation of oxygen metabolic process(GO:2000374) |
9.3 | 46.3 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
6.0 | 18.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
4.3 | 17.2 | GO:1903288 | protein transport into plasma membrane raft(GO:0044861) positive regulation of potassium ion import(GO:1903288) |
3.9 | 70.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
3.4 | 10.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
2.7 | 16.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.7 | 10.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.4 | 9.7 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.4 | 14.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
2.1 | 32.8 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.0 | 6.0 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
2.0 | 5.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
1.8 | 3.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.8 | 5.4 | GO:1990523 | bone regeneration(GO:1990523) |
1.7 | 29.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.4 | 14.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.4 | 5.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.3 | 3.9 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) |
1.3 | 5.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
1.3 | 10.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.2 | 3.7 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
1.2 | 9.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.2 | 6.1 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
1.2 | 3.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.1 | 3.4 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
1.0 | 7.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.9 | 4.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.9 | 8.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 2.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.9 | 0.9 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.9 | 3.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.8 | 11.9 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.8 | 5.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.8 | 15.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.8 | 5.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.8 | 5.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.8 | 2.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.8 | 3.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.8 | 3.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.7 | 4.5 | GO:1900107 | embryonic hindgut morphogenesis(GO:0048619) regulation of nodal signaling pathway(GO:1900107) |
0.7 | 6.7 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.7 | 2.9 | GO:1905123 | regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
0.7 | 3.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.7 | 9.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.7 | 11.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.6 | 8.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 2.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 2.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.6 | 7.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 1.8 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.6 | 2.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 1.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.6 | 5.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.6 | 7.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.5 | 2.5 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.5 | 6.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 3.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 4.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.5 | 2.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 2.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.5 | 14.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.5 | 1.4 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.4 | 1.8 | GO:0090677 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.4 | 3.0 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.4 | 3.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 22.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 5.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.4 | 2.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.4 | 2.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 8.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 2.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 8.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 3.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.4 | 8.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.4 | 1.8 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.4 | 2.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 12.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 1.7 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.3 | 2.3 | GO:0051597 | response to methylmercury(GO:0051597) |
0.3 | 5.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 1.6 | GO:1903035 | negative regulation of response to wounding(GO:1903035) |
0.3 | 2.5 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.3 | 13.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 4.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 1.8 | GO:2000669 | positive regulation of pinocytosis(GO:0048549) negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.3 | 1.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 2.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 1.1 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.3 | 1.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 2.8 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 2.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 3.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 1.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 3.2 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 6.6 | GO:0098743 | cell aggregation(GO:0098743) |
0.2 | 0.7 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.2 | 3.4 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.2 | 4.8 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.2 | 4.2 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.2 | 3.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 0.7 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 2.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 2.1 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.7 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.2 | 1.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 2.5 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 11.6 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 6.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 1.7 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.2 | 17.6 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 13.2 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.2 | 1.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 9.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 3.7 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.2 | 1.2 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 6.4 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.2 | 0.6 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
0.2 | 13.5 | GO:0030036 | actin cytoskeleton organization(GO:0030036) |
0.2 | 5.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.2 | 0.9 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 3.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 1.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 4.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 4.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 7.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 2.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 2.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 1.0 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 4.0 | GO:0065004 | nucleosome assembly(GO:0006334) protein-DNA complex assembly(GO:0065004) |
0.1 | 6.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 10.4 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
0.1 | 1.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 3.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.7 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 3.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 1.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 7.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.1 | 2.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.7 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.1 | 1.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 1.5 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 3.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 7.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 1.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.9 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 3.2 | GO:0007155 | cell adhesion(GO:0007155) biological adhesion(GO:0022610) |
0.1 | 2.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 6.0 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.3 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.1 | 2.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 17.6 | GO:0001654 | eye development(GO:0001654) |
0.1 | 1.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 5.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 2.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 1.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 2.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 1.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 2.0 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 3.0 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.0 | 3.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 1.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.7 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 6.2 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 1.7 | GO:0071466 | xenobiotic metabolic process(GO:0006805) response to xenobiotic stimulus(GO:0009410) cellular response to xenobiotic stimulus(GO:0071466) |
0.0 | 1.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 9.7 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.0 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 3.5 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.5 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 1.1 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 4.0 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 0.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.2 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 70.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
3.8 | 15.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.0 | 30.4 | GO:0097449 | astrocyte projection(GO:0097449) |
1.4 | 46.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.2 | 15.2 | GO:0097433 | dense body(GO:0097433) |
1.1 | 3.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
1.1 | 18.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.9 | 4.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.9 | 17.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.9 | 4.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.8 | 14.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.8 | 2.4 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.7 | 6.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 5.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.6 | 8.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.6 | 17.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.6 | 5.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 14.1 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 5.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 3.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 5.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 6.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.5 | 8.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.5 | 1.8 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 1.8 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.4 | 1.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 8.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 2.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.4 | 8.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 3.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 7.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 11.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 5.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 1.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 3.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 2.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 4.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 4.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 39.5 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 41.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 7.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 24.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 9.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 18.6 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 4.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 0.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 7.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 11.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 2.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.8 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 10.0 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 2.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 10.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 1.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 56.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.4 | GO:0001673 | male germ cell nucleus(GO:0001673) XY body(GO:0001741) |
0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 9.8 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 1.8 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 14.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 7.3 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 2.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.4 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 5.6 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.1 | 1.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 3.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 11.3 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 8.3 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 5.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.2 | GO:0031672 | A band(GO:0031672) |
0.0 | 19.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 2.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 16.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 3.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 4.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 1.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 7.6 | GO:0005856 | cytoskeleton(GO:0005856) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 11.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 3.4 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.7 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 4.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 1.8 | GO:1902495 | transmembrane transporter complex(GO:1902495) |
0.0 | 15.7 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.3 | 46.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
4.0 | 48.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.8 | 15.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
3.5 | 10.4 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
3.2 | 9.7 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
3.2 | 9.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
2.5 | 22.5 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.4 | 74.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
2.4 | 14.3 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
2.3 | 30.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
2.3 | 18.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.7 | 5.2 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.4 | 14.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
1.4 | 8.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
1.3 | 5.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
1.2 | 4.9 | GO:0030305 | heparanase activity(GO:0030305) |
1.1 | 9.2 | GO:0045545 | syndecan binding(GO:0045545) |
1.1 | 3.4 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
1.1 | 9.9 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 17.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.0 | 8.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.0 | 16.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.0 | 3.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.9 | 2.7 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.9 | 4.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.9 | 11.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.8 | 2.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.8 | 6.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.7 | 6.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 2.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.7 | 2.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.7 | 8.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.7 | 6.0 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.7 | 4.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.6 | 1.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 5.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.6 | 11.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.6 | 7.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 2.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.6 | 9.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 4.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.5 | 13.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 3.0 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.5 | 15.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 1.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.5 | 1.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 3.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 2.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 6.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 3.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.4 | 4.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 3.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 3.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.3 | 1.7 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.3 | 5.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 2.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 0.9 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.3 | 7.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 8.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 1.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.2 | 3.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 6.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 2.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 7.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 2.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 6.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 1.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 7.2 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 2.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 2.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 2.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 2.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 2.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 1.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 5.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 13.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 2.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.4 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 3.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 10.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 4.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 3.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 5.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 3.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 3.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 3.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 9.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 9.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 15.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 5.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 2.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 4.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 10.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 13.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 4.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 1.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 4.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 1.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 1.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 2.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 6.8 | GO:0008289 | lipid binding(GO:0008289) |
0.0 | 1.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 14.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 14.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 5.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 1.6 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 15.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 1.2 | GO:0005244 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.0 | 1.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 1.3 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 48.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.6 | 29.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 16.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 9.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 8.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 18.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 48.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 27.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 7.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 9.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 4.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 8.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 6.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 8.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 6.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 4.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 3.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 13.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 2.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 4.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 1.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 2.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 15.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.7 | 10.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 11.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 11.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 48.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 17.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 8.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 8.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 9.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 7.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 8.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 9.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 10.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 6.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 6.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 4.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 11.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 8.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 5.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 2.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 3.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 4.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 2.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 7.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 3.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 4.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 6.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 2.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 2.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 2.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 4.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 1.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 2.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 1.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 2.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 3.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 1.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |